Vascepa

Vascepa, also known as etravirine, is an oral medication used to treat high blood pressure in adults. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels to improve blood flow and lower blood pressure. Vascepa is typically prescribed as part of a comprehensive treatment plan that may include lifestyle modifications, such as a low-sodium diet and regular physical activity.

The most common side effects of Vascepa include dizziness, fatigue, and a temporary increase in blood pressure, known as the "orthostatic hypotension" effect. These side effects are usually mild and temporary. Serious side effects are rare but can include kidney problems, liver problems, and allergic reactions. It is important to inform your healthcare provider about any existing medical conditions, especially kidney or liver disease, before starting Vascepa.

Vascepa was approved by the U.S. Food and Drug Administration (FDA) in 2007 and the European Medicines Agency (EMA) in 2008. It is available in tablet form and is typically taken once daily. The medication is not recommended for use in children, pregnant women, or individuals with certain medical conditions, such as severe liver or kidney disease.

In summary, Vascepa is an effective medication for managing high blood pressure, but it should be used under the guidance of a healthcare professional to monitor for potential side effects and ensure it is suitable for individual needs. Always follow your healthcare provider's instructions and report any unusual symptoms or side effects promptly.